Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity. [electronic resource]
Producer: 20140421Description: 2384 p. digitalISSN:- 2041-1723
- Amidohydrolases -- antagonists & inhibitors
- Animals
- Anti-Obesity Agents -- pharmacology
- Antioxidants -- pharmacology
- Bacterial Proteins -- antagonists & inhibitors
- Cyclic N-Oxides -- pharmacology
- Diet, High-Fat -- adverse effects
- Gene Expression Regulation
- Glucose -- metabolism
- Intestinal Absorption -- drug effects
- Intestinal Mucosa -- metabolism
- Intestines -- drug effects
- Lactobacillus -- drug effects
- Lipid Metabolism -- drug effects
- Male
- Mice
- Mice, Knockout
- Microbiota -- drug effects
- Obesity -- drug therapy
- Receptors, Cytoplasmic and Nuclear -- antagonists & inhibitors
- Signal Transduction
- Spin Labels
- Taurocholic Acid -- agonists
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Intramural
There are no comments on this title.
Log in to your account to post a comment.